Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-09 Sale | 2026-03-11 4:11 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 479 | $2.536 | $1,215 | 618,276 (Indirect Direct) | View |
| 2026-03-09 Sale | 2026-03-11 4:10 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 247 | $2.536 | $626 | 514,304 (Direct) | View |
| 2026-02-03 Sale | 2026-02-05 4:14 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 323 | $1.822 | $589 | 514,551 (Direct) | View |
| 2025-12-22 Purchase | 2025-12-29 4:52 pm | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 58,060 | $0.8483 | $49,252 | 1,055,784 (Indirect Direct) | View |
| 2025-12-12 Purchase | 2025-12-16 6:38 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 52,000 | $0.5837 | $30,352 | 3,322,990 (Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:34 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 257 | $0.532 | $137 | 404,874 (Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:34 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 526 | $0.532 | $280 | 483,755 (Indirect Direct) | View |
| 2025-11-20 Sale | 2025-11-24 4:05 pm | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 5,462 | $0.501 | $2,736 | 997,724 (Indirect Direct) | View |
| 2025-11-19 Purchase | 2025-11-20 6:02 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 35,000 | $0.4951 | $17,329 | 3,271,453 (Direct) | View |
| 2025-11-17 Sale | 2025-11-19 4:19 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 32,456 | $0.454 | $14,735 | 3,236,453 (Direct) | View |
| 2025-11-03 Sale | 2025-11-05 4:01 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 292 | $0.586 | $171 | 405,131 (Direct) | View |
| 2025-09-08 Sale | 2025-09-10 5:34 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 263 | $0.5 | $132 | 405,423 (Direct) | View |
| 2025-09-08 Sale | 2025-09-10 5:29 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 488 | $0.5 | $244 | 3,268,909 (Direct) | View |
| 2025-09-08 Sale | 2025-09-10 5:28 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 539 | $0.5 | $270 | 484,281 (Indirect Direct) | View |
| 2025-08-04 Sale | 2025-08-06 4:13 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 296 | $0.534 | $158 | 405,686 (Direct) | View |
| 2025-06-09 Sale | 2025-06-11 5:05 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 4,904 | $0.622 | $3,050 | 405,982 (Direct) | View |
| 2025-06-09 Sale | 2025-06-11 5:05 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 552 | $0.622 | $343 | 250,141 (Direct) | View |
| 2025-06-09 Sale | 2025-06-11 5:05 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 475 | $0.622 | $295 | 1,681,783 (Direct) | View |
| 2025-06-09 Sale | 2025-06-11 5:04 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 526 | $0.622 | $327 | 484,820 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-11 Tax Withholding | 2026-03-13 4:07 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 55,397 | $2.73 | 3,710,958 (Direct) | View |
| 2026-03-11 Tax Withholding | 2026-03-13 4:05 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 1,431 | $2.73 | 1,187,742 (Direct) | View |
| 2026-03-06 Tax Withholding | 2026-03-10 7:53 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 463 | $2.56 | 3,766,355 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 5:12 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 31,172 | $1.75 | 3,766,818 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:22 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 1,420,000 | $0 | 4,742,990 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:19 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 400,000 | $0 | 883,755 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:15 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 400,000 | $0 | 1,454,173 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:12 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 335,000 | $0 | 739,874 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-06 4:10 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 1,611 | $0.995 | 1,054,173 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-12 4:16 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 463 | $0.526 | 3,270,990 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-11 6:04 pm | N/A 2035-12-09 | Century Therapeutics Inc. | IPSC | Lee Han Myung Director | 88,000 | $0 | 88,000 (Direct) | View |
| 2025-09-18 Option Award | 2025-09-22 4:56 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 762,543 | $0 | 1,003,186 (Direct) | View |
| 2025-08-14 Option Award | 2025-08-18 4:14 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 1,587,614 | $0 | 3,269,397 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 6:26 pm | N/A 2035-06-12 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 6:26 pm | N/A 2035-06-12 | Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 6:25 pm | N/A 2035-06-12 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 6:25 pm | N/A 2035-06-12 | Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 6:24 pm | N/A 2035-06-12 | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 6:23 pm | N/A 2035-06-12 | Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 6:23 pm | N/A 2035-06-12 | Century Therapeutics Inc. | IPSC | Walbert Timothy P Director | 44,000 | $0 | 44,000 (Direct) | View |